Some galE mutants of Salmonella choleraesuis retain virulence
- 1 December 1986
- journal article
- research article
- Published by American Society for Microbiology in Infection and Immunity
- Vol. 54 (3) , 635-640
- https://doi.org/10.1128/iai.54.3.635-640.1986
Abstract
GalE mutants were isolated from three mouse-virulent strains of Salmonella choleraesuis (of group C1, O antigen 6,7) by selection for resistance to 2-deoxygalactose. The galE derivative of strain 381 comprised two components: galactose sensitive, thought to be the original mutant; and galactose resistant, presumably by a second mutation reducing galK or galT function or both. The galactose-sensitive component had an intraperitoneal 50% lethal dose for BALB/c mice of ca. 4 .times. 106 CFU, whereas the galactose-resistant component was about as virulent as its gal+ parent, with a 50% lethal dose of ca. 100 CFU. The galE mutant of strain 110 was somewhat sensitive to galactose, as shown by retardation of growth; its 50% lethal dose, ca. 500 CFU, was not much greater than the ca. 200 CFU value for its parent. The galE mutant of strain 117 showed the same partial sensitivity to galactose as strain 110 galE, but was nonvirulent (50% lethal dose of ca. 106 CFU versus ca. 400 CFU for its parent). Growth on galactose-supplemented medium restored the smooth phenotype, as indicated by phage sensitivity to three of the four galE strains, but only partially so for the strain 117 galE mutant. The retention of parental virulence by galE mutants of S. choleraesuis which are galactose resistant or somewhat galactose sensitive contrast with the greatly reduced virulence of galactose-resistant galE mutants of Salmonella typhimurium and salmonella typhi; this difference may result from the absence of galactose from the O repeat unit in the lipopolysaccharide of group C1 salmonellae.This publication has 26 references indexed in Scilit:
- A Controlled Field Trial of Live Salmonella typhi Strain Ty 21a Oral Vaccine Against Typhoid: Three-Year ResultsThe Journal of Infectious Diseases, 1982
- Heterogeneity of Antigenic‐Side‐Chain Length in Lipopolysaccharide from Escherichia coli 0111 and Salmonella typhimurium LT2European Journal of Biochemistry, 1980
- Lipopolysaccharide Heterogeneity in Salmonella typhimurium Analyzed by Sodium Dodecyl Sulfate/Polyacrylamide Gel ElectrophoresisEuropean Journal of Biochemistry, 1980
- Evaluation of a UDP-Glucose-4-Epimeraseless Mutant of Salmonella typhi as a Live Oral VaccineThe Journal of Infectious Diseases, 1977
- Isolation and Characterization of Gal E Mutant Ty 21a of Salmonella typhi: A Candidate Strain for a Live, Oral Typhoid VaccineThe Journal of Infectious Diseases, 1975
- Non-smooth Mutants of Salmonella typhimurium: Differentiation by Phage Sensitivity and Genetic MappingJournal of General Microbiology, 1972
- The sensitivity of smooth and rough mutants ofSalmonella typhimurium to bactericidal and bacteriolytic action of serum, lysozyme and to phagocytosisFolia Microbiologica, 1968
- Analyses of Lipopolysaccharides Extracted from Penicillin-Resistant, Serum-Sensitive Salmonella MutantsJournal of General Microbiology, 1967
- Galactose-sensitive mutants of Salmonella II. Bacteriolysis induced by galactoseBiochimica et Biophysica Acta, 1961
- Galactose-sensitive Mutants of SalmonellaNature, 1959